Top

Published in:

01-09-2017 | Review Article

Barcelona Clinic Liver Cancer (BCLC) Staging: Does It Cover All Our Expectation

Author: Abdullah Sonsuz

Published in: Journal of Gastrointestinal Cancer | Issue 3/2017

Excerpt

Staging systems in hepatocellular carcinoma (HCC) are critically important to stratify the patients according to prognostic variables and to guide the available therapeutic approach for best survival. Although there are more than 15 scoring system and some of them are more common than other, there is not any consensus on best scoring strategy for HCC [1]. Barcelona Clinic Liver Cancers (BCLC) staging system is one of the most widely used scores in Europe and many other countries since 1999 [2]. …

Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver dis. 1999;19:329–38.CrossRef

Marrero JA, Kudo M, Bronowicki JP. The challenge of prognosis and staging for hepatocellular carcinoma. Oncologist. 2010;15(suppl 4):23–33.CrossRef

Llovet JM1, Di Bisceglie AM, Bruix J. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst. 2008;21;100(10):698–711.

Zhao YN, Zhang YQ, Ye JZ, et al. Hepatic resection versus transarterial chemoembolization for patients with Barcelona Clinic Liver Cancer intermediate stage Child-Pugh A hepatocellular carcinoma. Exp Ther Med. 2016;12(6):3813–9.CrossRef

Lin C-L, Lin C-K, Lin T-J, et al. Comparison of surgical resection and trans arterial chemoembolization for patients with intermediate stage hepatocellular carcinoma. Journal of Cancer Research and Practice. 2016;3:334–8.

Liu W, Zhou JG, Sun Y. Hepatic resection improved the long-term survival of patients with BCLC stage B hepatocellular carcinoma in Asia: a systematic review and meta-analysis. J Gastrointest Surg. 2015;19(7):1271–80.CrossRef

Yau T, Tang VY, Yao TJYau T. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology. 2014;146(7):1691–700.CrossRef

Sinn DH, Cho JY, Gwak GY, et al. Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread. PLoS One. 2015;29;10(4):e0124434.

Title: Barcelona Clinic Liver Cancer (BCLC) Staging: Does It Cover All Our Expectation
Author: Abdullah Sonsuz
Publication date: 01-09-2017
Publisher: Springer US
Published in: Journal of Gastrointestinal Cancer / Issue 3/2017
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-017-9963-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Barcelona Clinic Liver Cancer (BCLC) Staging: Does It Cover All Our Expectation

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2017

Cancer Stem Cells in Hepatocellular Carcinoma

Surveillance of the Patients with High Risk of Hepatocellular Cancer

HCC Locoregional Therapies: Yttrium-90 (Y-90) Selective Internal Radiation Therapy (SIRT)

Angiogenesis, Invasion, and Metastasis Characteristics of Hepatocellular Carcinoma

Validation of a Liver Index and Its Significance for HCC Aggressiveness

Hepatocellular Cancer: Is Recurrence Inevitable?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page